arrow
Back
A

Arun J. Sanyal

Virginia Commonwealth University

166H-index
1.4KPaper Count
15.0WCitation Count
Published Papers 678
Publication Date
Author Correction: Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial
err2026-08-25
err0
errOAAI
errLee M. Kaplan; Elena Startseva; Carel W. le Roux; Sean Wharton; Biykem Bozkurt; Daniel F. Mazo; Jessica von Schlippenbach; Sandra González Maldonado; Samina Ajaz Hussain; Guy W. Neff; Yaneicy Gonzalez Rojas; Charles Smith; Ramy Younes; Arun J. Sanyal
errShare
errSave
A precision-constrained framework for evaluating noninvasive biomarkers in MASLD and beyond
err2026-07-20
err0
errOAAI
errGuangyi Zhang; Xiaohong Wang; Arinc Ozturk; Eugene Cheah; Peng Guo; Marian Martin; Angela Shih; Atul K. Bhan; Nancy Obuchowski; Amon Asgharpour; Arun J. Sanyal; Brian A. Telfer; Theodore T. Pierce; Anthony E. Samir
errShare
errSave
The metabolic vulnerability index predicts outcomes in patients with metabolic dysfunction associated steatotic liver disease
err2026-06-23
err0
errOAAI
errMohammad S. Siddiqui; Mark L. Van Natta; Margery A. Connelly; Jeanne Clark; Brent A. Neuschwander-Tetri; Anna Mae Diehl; Srinivasan Dasarathy; Rohit Loomba; Naga Chalasani; Kris V. Kowdley; Bilal Hameed; Laura A. Wilson; Katherine P. Yates; Patricia Belt; David E. Kleiner; Cynthia Behling; James Tonascia; Arun J. Sanyal
errShare
errSave
Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial
err2026-06-07
err0
errOAAI
errLee M. Kaplan; Elena Startseva; Carel W. le Roux; Sean Wharton; Biykem Bozkurt; Daniel F. Mazo; Jessica von Schlippenbach; Sandra González Maldonado; Samina Ajaz Hussain; Guy W. Neff; Yaneicy Gonzalez Rojas; Charles Smith; Ramy Younes; Arun J. Sanyal
errShare
errSave
A reasonably likely surrogate endpoint for metabolic dysfunction–associated steatohepatitis
err2026-04-28
err0
PREAI
errArun J. Sanyal; Michelle T. Long; Nancy Obuchowski; Roberto A. Calle; Raj Vuppalanchi; Brent Neuschwander-Tetri; Rohit Loomba; Katherine Yates; Patricia Grebenstein; Melissa A. Jones; Tania N. Kamphaus
errShare
errSave
Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial
err2026-04-02
err0
errOAAI
errSebastian M. Meyhöfer; Bertrand Cariou; Cintia Cercato; Helen M. Colhoun; John Deanfield; Michelle T. Long; Ole Kleist Jeppesen; A. Michael Lincoff; Ildiko Lingvay; Jorge Plutzky; Philip N. Newsome; Stephen J. Nicholls; Maria Quiroga; Ferruccio Santini; Arun J. Sanyal; Steven E. Kahn
errShare
errSave
Cardiovascular Risk Assessment Tools are Insufficient for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
err2026-03-01
err6
PREAI
errBarritt, A. Sidney; Tapper, Elliot B.; Newsome, Philip N.; Gazis, Derek; Morris, Heather; Mospan, Andrea R.; Perez, Anthony Daniel; Kim, Yestle; Neuschwander-Tetri, Brent A.; Loomba, Rohit; Sanyal, Arun
errShare
errSave
Disease-Driven Loss of Inactive HSD17B13 Isoforms Enhances Enzymatic Output in MASH and Counters Protective rs72613567:TA Variant
err2026-02-23
err0
errOAAI
errJohn Min; Mulugeta Seneshaw; Faridoddin Mirshahi; Hae-Ki Min; Arun J. Sanyal
errShare
errSave
AI-assisted fibrosis scoring in MASH: Exploring pathologist decision-making with an SHG-based AI digital pathology tool
err2026-01-29
err0
errOAAI
errDesiree Abdurrachim; Aileen Wee; Gwyneth Soon; Michael Idowu; Timothy J. Kendall; Serene Lek; Gideon Ho; Samuel S. Engel; Saswata Talukdar; Chih-Liang Chin; Asad Abu Bakar Ali; Arun J. Sanyal; David E. Kleiner
errShare
errSave
MASLD as a complication of obesity must include liver risk stratification
err2026-01-07
err0
PREAI
errMary E. Rinella; Arun J. Sanyal; Rohit Loomba; Mazen Noureddin; Meena B. Bansal; Philip N. Newsome; Vlad Ratziu
errShare
errSave
Histological severity and hepatic outcomes in patients with metabolic dysfunction-associated steatotic liver disease and discrepant FIB-4 and liver stiffness measurement
err2026-01-01
err1
PREAI
errRabbat, Joseph; Yang, Boyu; Lee, Hye Won; Lin, Huapeng; Tsochatzis, Emmanuel; Petta, Salvatore; Bugianesi, Elisabetta; Yoneda, Masato; Zheng, Ming-Hua; Hagstrom, Hannes; Boursier, Jerome; Calleja, Jose Luis; Goh, George Boon-Bee; Chan, Wah-Kheong; Gallego-Duran, Rocio; Sanyal, Arun J.; De Ledinghen, Victor; Newsome, Philip N.; Fan, Jian-Gao; Castera, Laurent; Lai, Michelle; Fournier-Poizat, Celine; Wong, Grace Lai-Hung; Zoncape, Mirko; Pennisi, Grazia; Armandi, Angelo; Nakajima, Atsushi; Liu, Wen-Yue; Shang, Ying; De Saint-Loup, Marc; Llop, Elba; Teh, Kevin Kim Jun; Lara-Romero, Carmen; Asgharpour, Amon; Mahgoub, Sara; Chan, Mandy Sau-Wai; Canivet, Clemence M.; Romero-Gomez, Manuel; Wong, Vincent Wai-Sun; Kim, Seung Up; Yip, Terry Cheuk-Fung
errShare
errSave
Association of Components of Metabolic Syndrome and the Progression of Nonalcoholic Fatty Liver Disease
err2026-01-01
err3
PREAI
errLe, Phuc; Tatar, Moosa; Rothberg, Michael B.; Wilson, Laura A.; Allende, Daniela; Diehl, Anna Mae; Loomba, Rohit; Chalasani, Naga; Neuschwander-Tetri, Brent A.; Kowdley, Kris; Sanyal, Arun J.; Tonascia, James; Dasarathy, Srinivasan
errShare
errSave
Expert Delphi consensus on surrogate endpoints for treatment assessment in metabolic dysfunction-associated steatohepatitis
err2025-12-06
err0
PREAI
errArun J. Sanyal; Atsushi Nakajima; Elisabetta Bugianesi; Giada Sebastiani; Jörn M. Schattenberg; Leon A. Adams; Mazen Noureddin; Masato Yoneda; Pierre Bedossa; Zobair M. Younossi; Assim A. Alfadda; Andreas Geier; Frank Tacke; Giulio Marchesini; Giovanni Targher; Hussain Abdulrahman Al-Omar; Hannes Hagström; Juan G. Abraldes; Jerome Boursier; Kento Imajo
errShare
errSave
Serial measurements of NIS2+® enable monitoring disease evolution in patients with MASH: A retrospective cohort analysis
err2025-12-01
err0
PREAI
errSanyal, Arun J.; Ratziu, Vlad; Hajji, Yacine; Magnanensi, Jeremy; Deledicque, Sylvie; Majd, Zouher; Hum, Dean W.; Staels, Bart; Connelly, Margery A.; Francque, Sven; Anstee, Quentin M.
errShare
errSave
Association between pattern of hepatic iron deposition and severity of MASH among patients enrolled in the NASH Clinical Research Network
err2025-12-01
err0
PREAI
errSohal, Aalam; Wilson, Laura A.; Kleiner, David E.; Loomba, Rohit; Yuan, Liyun; Dasarathy, Srinivasan; Sanyal, Arun J.; Neuschwander-Tetri, Brent A.; Chalasani, Naga P.; Diehl, Anna Mae; Kowdley, Kris V.
errShare
errSave
Additional Cover
err2025-10-19
err0
errOAAI
errLouis Petitjean; Li Chen; Xiaofei Zhang; Thomas Schiano; Mathieu Petitjean; Arun J. Sanyal; MariaIsabel Fiel
errShare
errSave
The global cardiovascular–liver–metabolic syndemic: epidemiology, trends and challenges
err2025-10-06
err0
PREAI
errNicholas W. S. Chew; Anurag Mehta; Rachel Goh; Jaycie Koh; Yiming Chen; Bryan Chong; Mark Y. Chan; Muhammad Shahzeb Khan; Mark D. Muthiah; Javed Butler; Arun J. Sanyal; Laurence S. Sperling
errShare
errSave
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease
err2025-09-26
err0
PREAI
errLuis Antonio Diaz; Maja Thiele; Alexandre Louvet; Brian P. Lee; Veeral Ajmera; Federica Tavaglione; Cynthia L. Hsu; Daniel Q. Huang; Elisa Pose; Ramon Bataller; Craig McClain; Jessica Mellinger; Monica Tincopa; Mack C. Mitchell; Vlad Ratziu; Mary E. Rinella; Shiv K. Sarin; Vijay H. Shah; Gyongyi Szabo; Vincent Wai-Sun Wong; Meena B. Bansal; Lorenzo Leggio; Patrick S. Kamath; Aleksander Krag; Arun J. Sanyal; Marco Arrese; Juan Pablo Arab; Quentin M. Anstee; Philippe Mathurin; Rohit Loomba
errShare
errSave
Genetic and non-genetic drivers of histological progression and regression in MASLD
err2025-09-24
err0
PREAI
errEduardo Vilar-Gomez; Katherine P. Yates; David E. Kleiner; Cynthia Behling; Oscar W. Cummings; Laura A. Wilson; Tiebing Liang; Chaowapong Jarasvaraparn; Rohit Loomba; Jeffrey B. Schwimmer; Arun J. Sanyal; Jay Hoofnagle; Naga Chalasani
errShare
errSave
Exploration of Multiple Non-Invasive Tests for Assessing Response to Treatment in a Semaglutide Phase 2b Trial in Patients with MASH
err2025-09-23
err0
errOAAI
errLouise Maymann Nitze; Vlad Ratziu; Arun J. Sanyal; Vincent Wai-Sun Wong; Clare Balendran; Jan Fleckner; Mette Skalshøi Kjær; Niels Krarup; Quentin M. Anstee
errShare
errSave